In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

Free Radical Biology and Medicine - Tập 48 - Trang 136-144 - 2010
D. Allan Butterfield1, Veronica Galvan2, Miranda Bader Lange1, Huidong Tang2, Renã A. Sowell1, Patricia Spilman2, Joanna Fombonne2, Olivia Gorostiza2, Junli Zhang2, Rukhsana Sultana1, Dale E. Bredesen2,3
1Department of Chemistry, Center of Membrane Sciences, and Sanders–Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA
2Buck Institute for Age Research, Novato, CA 94945, USA
3Department of Neurology, University of California at San Francisco, San Francisco, CA 94143, USA

Tài liệu tham khảo

Butterfield, 1997, β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease, Chem. Res. Toxicol., 10, 495, 10.1021/tx960130e Butterfield, 2006, Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease, Neurobiol. Dis., 22, 223, 10.1016/j.nbd.2005.11.002 Butterfield, 2007, Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment, Free Radic. Biol. Med., 43, 658, 10.1016/j.freeradbiomed.2007.05.037 Butterfield, 2006, Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment, Neurosci. Lett., 397, 170, 10.1016/j.neulet.2005.12.017 Butterfield, 2007, Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease, Brain Res., 1148, 243, 10.1016/j.brainres.2007.02.084 Hensley, 1995, Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem., 65, 2146, 10.1046/j.1471-4159.1995.65052146.x Keller, 2005, Evidence of increased oxidative damage in subjects with mild cognitive impairment, Neurology, 64, 1152, 10.1212/01.WNL.0000156156.13641.BA Lyras, 1997, An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease, J. Neurochem., 68, 2061, 10.1046/j.1471-4159.1997.68052061.x Markesbery, 1997, Oxidative stress hypothesis in Alzheimer's disease, Free Radic. Biol. Med., 23, 134, 10.1016/S0891-5849(96)00629-6 Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci., 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997 Varadarajan, 2000, Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity, J. Struct. Biol., 130, 184, 10.1006/jsbi.2000.4274 Reed, 2008, Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease, Neurobiol. Dis., 30, 107, 10.1016/j.nbd.2007.12.007 Reed, T. T.; Pierce, W. M., Jr.; Turner, D. M.; Markesbery, W. R.; Butterfield, D. A. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J. Cell. Mol. Med. (in press); 2008. doi:10.1111/j.1582-4934.2008.00478.x. Sultana, 2007, Proteomics analysis of the Alzheimer's disease hippocampal proteome, J. Alzheimers Dis., 11, 153, 10.3233/JAD-2007-11203 Sultana, 2006, Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis, Neurobiol. Aging, 27, 918, 10.1016/j.neurobiolaging.2005.05.005 Sultana, 2006, Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD, Neurobiol. Aging, 27, 1564, 10.1016/j.neurobiolaging.2005.09.021 Sultana, 2007, Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study, J. Cell. Mol. Med., 11, 839, 10.1111/j.1582-4934.2007.00065.x Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200 Selkoe, 2008, Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior, Behav. Brain Res., 192, 106, 10.1016/j.bbr.2008.02.016 Viola, 2008, Why Alzheimer's is a disease of memory: the attack on synapses by Ab oligomers (ADDLs), J. Nutr. Health Aging, 12, 51S, 10.1007/BF02982587 Drake, 2003, Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model, Neurobiol. Aging, 24, 415, 10.1016/S0197-4580(02)00225-7 Walsh, 2002, Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a Ansari, 2006, In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid β-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders, Free Radic. Biol. Med., 41, 1694, 10.1016/j.freeradbiomed.2006.09.002 Boyd-Kimball, 2004, Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity, Chem. Res. Toxicol., 17, 1743, 10.1021/tx049796w Pappolla, 1999, Alzheimer β protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin, J. Pineal Res., 27, 226, 10.1111/j.1600-079X.1999.tb00619.x Sultana, 2005, Ferulic acid ethyl ester protects neurons against amyloid β-peptide(1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity, J. Neurochem., 92, 749, 10.1111/j.1471-4159.2004.02899.x Abdul, 2008, Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age, Free Radic. Biol. Med., 45, 1420, 10.1016/j.freeradbiomed.2008.08.012 Boyd-Kimball, 2005, Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: implications for Alzheimer's disease, Neuroscience, 132, 313, 10.1016/j.neuroscience.2004.12.022 Mohmmad Abdul, 2006, Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β-peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease, J. Neurochem., 96, 1322, 10.1111/j.1471-4159.2005.03647.x Resende, 2008, Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease, Free Radic. Biol. Med., 44, 2051, 10.1016/j.freeradbiomed.2008.03.012 Zhu, 2008, Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2, Free Radic. Biol. Med., 45, 1493, 10.1016/j.freeradbiomed.2008.08.027 Yatin, 1999, In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1–42), Neurobiol. Aging, 20, 325 Butterfield, 2005, The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity, Biochim. Biophys. Acta, 1703, 149, 10.1016/j.bbapap.2004.10.014 Kanski, 2002, Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide, Free Radic. Biol. Med., 32, 1205, 10.1016/S0891-5849(02)00821-3 Varadarajan, 2001, Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1–42) and Aβ(25–35), J. Am. Chem. Soc., 123, 5625, 10.1021/ja010452r Galvan, 2006, Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664, Proc. Natl. Acad. Sci. USA, 103, 7130, 10.1073/pnas.0509695103 Butterfield, 1997, Protein oxidation processes in aging brain, Adv. Cell Aging Gerontol., 2, 161, 10.1016/S1566-3124(08)60057-7 Lauderback, 2001, The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Aβ1–42, J. Neurochem., 78, 413, 10.1046/j.1471-4159.2001.00451.x Morris, 1984, Development of a water-maze procedure for studying spatial learning in the rat, J. Neurosci. Methods, 11, 47, 10.1016/0165-0270(84)90007-4 Aksenov, 2001, Protein oxidation in the brain in Alzheimer's disease, Neuroscience, 103, 373, 10.1016/S0306-4522(00)00580-7 Galvan, 2008, Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664, Behav. Brain Res., 191, 246, 10.1016/j.bbr.2008.03.035 Saganich, 2006, Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP, J. Neurosci., 26, 13428, 10.1523/JNEUROSCI.4180-06.2006 Stadtman, 2004, Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation, Arch. Biochem. Biophys., 423, 2, 10.1016/j.abb.2003.10.001 Vogt, 1995, Oxidation of methionyl residues in proteins: tools, targets, and reversal, Free Radic. Biol. Med., 18, 93, 10.1016/0891-5849(94)00158-G Bose-Basu, 2004, Dynamic characterization of a DNA repair enzyme: NMR studies of [methyl-13C]methionine-labeled DNA polymerase b, Biochemistry, 43, 8911, 10.1021/bi049641n Schoneich, 2002, Redox processes of methionine relevant to β-amyloid oxidation and Alzheimer's disease, Arch. Biochem. Biophys., 397, 370, 10.1006/abbi.2001.2621 Subramaniam, 1997, The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins, J. Neurochem., 69, 1161, 10.1046/j.1471-4159.1997.69031161.x Sayre, 1997, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem., 68, 2092, 10.1046/j.1471-4159.1997.68052092.x Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 11, 81, 10.1016/0891-5849(91)90192-6 Mark, R.J.; Lovell, M.A.; Markesbery, W.R.; Uchida, K.; Mattson, M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68:255–264; 1997. Kadlcik, 2004, One-electron oxidation of β-amyloid peptide: sequence modulation of reactivity, Free Radic. Biol. Med., 37, 881, 10.1016/j.freeradbiomed.2004.06.015 Clementi, 2006, Alzheimer's amyloid β-peptide (1–42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35, Biochem. Biophys. Res. Commun., 342, 206, 10.1016/j.bbrc.2006.01.137 Dai, 2007, Attenuated cytotoxicity but enhanced β-fibril of a mutant amyloid β-peptide with a methionine to cysteine substitution, FEBS Lett., 581, 1269, 10.1016/j.febslet.2007.02.038 Murray, 2005, Promotion of oxidative lipid membrane damage by amyloid β proteins, Biochemistry, 44, 12606, 10.1021/bi050926p Crouch, 2006, Copper-dependent inhibition of cytochrome c oxidase by Aβ(1–42) requires reduced methionine at residue 35 of the Aβ peptide, J. Neurochem., 99, 226, 10.1111/j.1471-4159.2006.04050.x Gomez-Balderas, 2005, Computational studies of Cu(II)/Met and Cu(I)/Met binding motifs relevant for the chemistry of Alzheimer's disease, J. Phys. Chem., A, 109, 5498, 10.1021/jp050843i Cherny, 2001, Treatment with a copper–zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron, 30, 665, 10.1016/S0896-6273(01)00317-8 Huang, 1999, Cu(II) potentiation of Alzheimer Aβ neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction, J. Biol. Chem., 274, 37111, 10.1074/jbc.274.52.37111 Smith, 1998, Amyloid-beta deposition in Alzheimer-transgenic mice is associated with oxidative stress, J. Neurochem., 70, 2212, 10.1046/j.1471-4159.1998.70052212.x Nunomura, 2007, Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases, CNS Neurol. Disord. Drug Targets, 6, 411, 10.2174/187152707783399201 Opii, 2008, Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease, Neurobiol. Aging, 29, 51, 10.1016/j.neurobiolaging.2006.09.012 Lu, 2000, A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor, Nat. Med., 6, 397, 10.1038/74656 Madeira, 2005, SET protein (TAF1b, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain, FASEB J., 19, 1905, 10.1096/fj.05-3839fje Nikolaev, 2009, APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, Nature, 457, 981, 10.1038/nature07767